输血相关性急性肺损伤(transfusion-related acute lung in-jury,TRALI)是输血引起的急性呼吸窘迫综合症(ARDS),死亡率为5%—14%[1],在美国输血相关死亡原因中排列第3。但在临床工作中,由于其临床症状的非特异性、临床诊断的排他性以及实验室检查的复杂性,导致临床医生对这一致 Transfusion-related acute lung injury (TRALI) is a transfusion-induced acute respiratory distress syndrome (ARDS) with a 5% -14% mortality rate [1]. In the United States, transfusion-related deaths Ranked third. However, clinical work, due to its non-specific clinical symptoms, the exclusion of clinical diagnosis and the complexity of laboratory tests, leading clinicians to this agreement